-
- May 13/25
New enzyme tech offers hope for mitochondrial disease treatment - May 13/25
Cracking the code to scalable cell and gene therapy - May 13/25
Scientists film the heart forming in 3D earlier than ever before - May 12/25
Mass photometry technique speeds up quality control in gene therapy vector production - May 12/25
Pharma giants pull back on AAV research: What’s next for the gene therapy space? - May 12/25
Saving teeth through regeneration offers long-term benefits over implants - May 12/25
Systemic gaps hinder cell and gene therapy adoption, access - May 12/25
Stanford Medicine study reveals CAR-T cell therapy for cancer may trigger “brain fog” - May 12/25
Gene editing for muscular dystrophies: Where do we stand? - May 8/25
Allele-selective gene editing: a breakthrough in Huntington’s disease treatment - May 8/25
Two new trials explore stem-cell therapy for Parkinson’s - May 7/25
Synthetic nanoparticle eyedrops help corneas heal after chemical or inflammatory damage - May 7/25
FaSt-Light: Transforming in situ biofabrication for tissue repair - May 7/25
Advanced CAR T cell therapy presents breakthrough approach for lymphoma treatment - May 7/25
CRISPR’s Casgevy on the rise with more gene therapy proof of concept to come in 2025 - May 6/25
New hybrid technology enhances precision in stem cell therapy for brain diseases - May 6/25
Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic - May 6/25
Can space help heal hearts? ISS study charts new path for stem cell therapy - May 6/25
Getting the right gene therapy to the right tissue - May 6/25
Gene therapy offers new hope for telomere diseases - May 6/25
AstraZeneca debuts $300M cell therapy manufacturing facility in Maryland - May 5/25
CIAO study: Unveiling the secrets of human longevity and healthy aging through long-term research - May 5/25
Vertex abandons AAV as gene therapy space weathers difficulties - May 5/25
J&J gene therapy fails to improve visual navigation in late-stage rare eye disease trial - May 5/25
Three CAR-T therapies to capture over 70% of T-cell immunotherapy market - May 5/25
US FDA to convene expert panel for Capricor Therapeutics’ DMD cell therapy - May 4/25
B-cell targeting therapies may break ‘evolving cycle’ of lupus - May 1/25
Targeting zombie cells: a new treatment for chronic back pain - May 1/25
Laser-based analytical platform enhances CAR T cell therapy manufacturing and effectiveness - May 1/25
Inhalable gene therapies? Here’s how they could work - May 1/25
These breakthrough gene therapies cost millions of dollars. Is a mortgage model the secret to paying for them? - May 1/25
Study confirms safety of genetically modified T cells - Apr 30/25
Investigational gene therapy gives children with rare immune disorder a new lease on life - Apr 30/25
The promise of autologous and allogeneic cell therapies - Apr 30/25
Clusterin levels indicate aging in hematopoietic stem cells - Apr 30/25
AI vs. humans in novel drug target identification - Apr 30/25
Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy - Apr 30/25
CAR T-cell therapy achieves positive results in refractory lymphoma patients - Apr 30/25
With mitochondria transplantation, researchers aim to revolutionize the treatment of disease - Apr 30/25
How AI is accelerating the future of regenerative medicine - Apr 30/25
Gene therapy research roundup: Gene circuits and controlling capsids with machine learning - Apr 29/25
New CAR T cell therapy shows promise for treating advanced thyroid cancer - Apr 29/25
Viral RNA-guided genome editing enables transgene-free arabidopsis - Apr 29/25
Crowdsourcing the brain: Meta-atlas reveals new clues about development and disease - Apr 29/25
Abeona cell therapy approved by FDA for rare skin condition - Apr 29/25
Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma - Apr 28/25
An innovative approach to treating cystic fibrosis using base editors - Apr 28/25
Lab-grown liver breakthrough could speed up drug development - Apr 28/25
Gene circuits enable more precise control of gene therapy - Apr 28/25
Cell and gene therapy sector enters ‘critical’ period after Marks’ FDA exit - Apr 28/25
First patient to receive gene therapy treatment developed at Children’s Hospital of Philadelphia living pain-free
- May 13/25
